X Lin, LM DeAngelis - Journal of clinical oncology, 2015 - ascopubs.org
Brain metastases (BMs) occur in 10% to 20% of adult patients with cancer, and with increased surveillance and improved systemic control, the incidence is likely to grow …
V Gondi, G Bauman, L Bradfield, SH Burri… - Practical radiation …, 2022 - Elsevier
Purpose This guideline provides updated evidence-based recommendations addressing recent developments in the management of patients with brain metastases, including …
PD Brown, K Jaeckle, KV Ballman, E Farace… - Jama, 2016 - jamanetwork.com
Importance Whole brain radiotherapy (WBRT) significantly improves tumor control in the brain after stereotactic radiosurgery (SRS), yet because of its association with cognitive …
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic …
Background It is unclear whether the benefit of adding whole-brain radiation therapy (WBRT) to stereotactic radiosurgery (SRS) for the control of brain-tumours outweighs the …
R Soffietti, M Kocher, UM Abacioglu, S Villa… - Journal of clinical …, 2013 - ascopubs.org
Purpose This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with observation after either surgery or radiosurgery of a limited number of brain metastases in …
MN Tsao, D Rades, A Wirth, SS Lo… - Practical radiation …, 2012 - Elsevier
Purpose To systematically review the evidence for the radiotherapeutic and surgical management of patients newly diagnosed with intraparenchymal brain metastases. Methods …
PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh… - International Journal of …, 2010 - Elsevier
PURPOSE: Controversy endures regarding the optimal treatment of patients with brain metastases (BMs). Debate persists, despite many randomized trials, perhaps because BM …
Purpose: We report the intracranial efficacy of selpercatinib, a highly potent and selective RET inhibitor, approved in the United States for RET fusion-positive non–small cell lung …